Vortioxetine treatment for major depressive disorder with the co-morbidity of irritable bowel syndrome with diarrhoea: a case report

Irritable bowel syndrome (IBS) is a complex condition that involves problems with bowel movements and belly pain, bloating, and gas. It is not life threatening, but can be a long-lasting problem that changes life quality. Several studies have shown that up to 70–90% of patients with IBS who seek tre...

Full description

Bibliographic Details
Main Authors: Orkun Aydin, Pınar Ünal-Aydin
Format: Article
Language:English
Published: AVES 2018-01-01
Series:Psychiatry and Clinical Psychopharmacology
Subjects:
Online Access:http://dx.doi.org/10.1080/24750573.2017.1387403
_version_ 1828027841655078912
author Orkun Aydin
Pınar Ünal-Aydin
author_facet Orkun Aydin
Pınar Ünal-Aydin
author_sort Orkun Aydin
collection DOAJ
description Irritable bowel syndrome (IBS) is a complex condition that involves problems with bowel movements and belly pain, bloating, and gas. It is not life threatening, but can be a long-lasting problem that changes life quality. Several studies have shown that up to 70–90% of patients with IBS who seek treatment have psychiatric co-morbidity, most notably mood and anxiety disorders. There are different approaches in the medication for IBS. Antidepressants such as tricyclic antidepressants and selective serotonin reuptake inhibitors are shown to be useful in the treatment. Vortioxetine may become a possible new agent in the treatment of patients with major depressive disorder and IBS with diarrhoea co-morbidity.
first_indexed 2024-04-10T13:43:23Z
format Article
id doaj.art-42f2fb5ed201493688adff1815c0d12b
institution Directory Open Access Journal
issn 2475-0573
2475-0581
language English
last_indexed 2024-04-10T13:43:23Z
publishDate 2018-01-01
publisher AVES
record_format Article
series Psychiatry and Clinical Psychopharmacology
spelling doaj.art-42f2fb5ed201493688adff1815c0d12b2023-02-15T16:11:05ZengAVESPsychiatry and Clinical Psychopharmacology2475-05732475-05812018-01-0128110710910.1080/24750573.2017.13874031387403Vortioxetine treatment for major depressive disorder with the co-morbidity of irritable bowel syndrome with diarrhoea: a case reportOrkun Aydin0Pınar Ünal-Aydin1Haliç UniversityHaliç UniversityIrritable bowel syndrome (IBS) is a complex condition that involves problems with bowel movements and belly pain, bloating, and gas. It is not life threatening, but can be a long-lasting problem that changes life quality. Several studies have shown that up to 70–90% of patients with IBS who seek treatment have psychiatric co-morbidity, most notably mood and anxiety disorders. There are different approaches in the medication for IBS. Antidepressants such as tricyclic antidepressants and selective serotonin reuptake inhibitors are shown to be useful in the treatment. Vortioxetine may become a possible new agent in the treatment of patients with major depressive disorder and IBS with diarrhoea co-morbidity.http://dx.doi.org/10.1080/24750573.2017.1387403Vortioxetinedepressionirritable bowel syndromediarrhoea
spellingShingle Orkun Aydin
Pınar Ünal-Aydin
Vortioxetine treatment for major depressive disorder with the co-morbidity of irritable bowel syndrome with diarrhoea: a case report
Psychiatry and Clinical Psychopharmacology
Vortioxetine
depression
irritable bowel syndrome
diarrhoea
title Vortioxetine treatment for major depressive disorder with the co-morbidity of irritable bowel syndrome with diarrhoea: a case report
title_full Vortioxetine treatment for major depressive disorder with the co-morbidity of irritable bowel syndrome with diarrhoea: a case report
title_fullStr Vortioxetine treatment for major depressive disorder with the co-morbidity of irritable bowel syndrome with diarrhoea: a case report
title_full_unstemmed Vortioxetine treatment for major depressive disorder with the co-morbidity of irritable bowel syndrome with diarrhoea: a case report
title_short Vortioxetine treatment for major depressive disorder with the co-morbidity of irritable bowel syndrome with diarrhoea: a case report
title_sort vortioxetine treatment for major depressive disorder with the co morbidity of irritable bowel syndrome with diarrhoea a case report
topic Vortioxetine
depression
irritable bowel syndrome
diarrhoea
url http://dx.doi.org/10.1080/24750573.2017.1387403
work_keys_str_mv AT orkunaydin vortioxetinetreatmentformajordepressivedisorderwiththecomorbidityofirritablebowelsyndromewithdiarrhoeaacasereport
AT pınarunalaydin vortioxetinetreatmentformajordepressivedisorderwiththecomorbidityofirritablebowelsyndromewithdiarrhoeaacasereport